Orthobiologics Strategy: FDA Issues New Warning about Sales of Unapproved Products
FDA doubled down on its enforcement commitment for Human Cell and Tissue Products after its enforcement discretion ended in May. Jun 22, 2021
Orthobiologics Face Pressure from Lack of Clinical Evidence
In the race to capitalize on patient-driven interest in stem cells, biologic solutions and “regeneration” of a more vital, healthy and functional body, there has been an explosion of offerings that lack scientific controls, validity and meaningful evidence. Mar 18, 2020
The Age of Biology Comes to Orthopaedics
In the field of orthopaedic surgery, over the last 100 years we have migrated from therapies based on limb removal to joint replacement to tissue repair, and we are beginning to see clinical solutions for tissue regeneration. These four Rs represent the history and future of clinical orthopaedics. Apr 20, 2018
